ST Phi Therapeutics, Inc. — Form D
ST Phi Therapeutics, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-09. The offering totals $500K, of which $500K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-01-09
- Form: D
- Accession: 0001727316-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $500K
- Investors: 1
- Date of first sale: 2018-01-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-302739
Issuer
- Name: ST Phi Therapeutics, Inc.
- CIK: 0001727316
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: STARTUP HALL, BOX 354625, SEATTLE, WA, 98195
- Phone: 206-518-1538
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Xiaobin Guo | Director | Seattle, WA |
| Lingfeng Liu | Director | Seattle, WA |
| Xiaobin Guo | Executive Officer | Seattle, WA |
| Lingfeng Liu | Executive Officer | Seattle, WA |
More